|
|
||||||||
1 Dept of Medicine, Keio University School of Medicine, Tokyo, Japan. 2 Experimental Medicine Unit, University of Wales Swansea, Swansea, UK. 3 Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
CORRESPONDENCE: K. Asano, Cardiopulmonary Division, Dept of Medicine, Keio University School of Medicine, 35 Shinanomachi, Tokyo, 160-8582, Japan. Fax: 81 333532502
This study was in part supported by Keio University Grant-in-Aid for Encouragement of Young Medical Scientists (KF), Grant-in-Aid for Scientific Research from the Ministry of Science, Education, and Culture of Japan (TS), and a research grant (JMH) from Mitsubishi Chemical Co. (Tokyo, Japan).
Whole genome scan analyses have revealed that chromosomal region 3p21
Three polymorphisms were identified using the single stranded conformational polymorphism method in Japanese (Asian) and British (Caucasian) subjects; one silent mutation T51C and two missense mutations G824A and T971C. These polymorphisms were examined in 391 Japanese subjects (210 asthmatics and 181 nonasthmatic controls) and 234 British subjects (142 asthmatics and 92 nonasthmatic controls). Asthma diagnosis was based on episodic symptoms, documented wheeze, and the presence of reversible airflow limitation.
CCR3 T51C demonstrated a significant association with the diagnosis of asthma in the British population (odds ratio 2.35, p<0.01), but not in the Japanese population. Multiple logistic regression analysis also showed that CCR3 T51C was associated with asthma (odds ratio 2.83, p<0.02), independent of atopic phenotypes such as high levels of total or house dust mite-specific immunoglobulin-E in serum.
In conclusion, a significant association between asthma and CCR3 T51C polymorphism localized on chromosome 3p21
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |